LLY logo Eli Lilly and Company +
Eli Lilly and Company
+

Eli Lilly and Company's Revenue (2016 - 2025)

  • Eli Lilly and Company's annual revenue was $65.18 B in fiscal year 2025. The annual revenue increased $20.14 B from $45.04 B (in 2024) to $65.18 B (in 2025), representing a 44.70% year-over-year growth. ... See more

  • Eli Lilly and Company's quarterly revenue was $22.97 B in the quarter ending Jun 2026. The quarterly revenue increased $7.42 B from $15.56 B (in Q2: Mar 2025) to $22.97 B (in Q2: Mar 2026), representing a 47.67% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
  • The highest annual revenue for Eli Lilly and Company was $65.18 B in fiscal year 2025.
  • The lowest annual revenue was $19.97 B in fiscal year 2017.
  • The average revenue was $31.08 B.

    • Learn more about Eli Lilly and Company's Revenue by Segment and Revenue by Region.

    Check out competitors to Eli Lilly and Company in a side-by-side comparison.

    Explore additional financial metrics for Eli Lilly and Company.


    Definition of Revenue :
  • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
    • Continue reading...
... See more

Eli Lilly and Company's Revenue Trend

Last Updated: Jun 30, 2026 |

2025

Eli Lilly and Company's annual revenue was $65.18 B in fiscal year 2025.

Eli Lilly and Company's quarterly revenue was $12.73 B(Q1: Mar 2025), $15.56 B(Q2: Jun 2025), $17.60 B(Q3: Sep 2025), $19.29 B(Q4: Dec 2025) in fiscal year 2025. ... See more

2024

Eli Lilly and Company's annual revenue was $45.04 B in fiscal year 2024.

Eli Lilly and Company's quarterly revenue was $8.77 B(Q1: Mar 2024), $11.30 B(Q2: Jun 2024), $11.44 B(Q3: Sep 2024), $13.53 B(Q4: Dec 2024) in fiscal year 2024.

2023

Eli Lilly and Company's annual revenue was $34.12 B in fiscal year 2023.

Eli Lilly and Company's quarterly revenue was $6.96 B(Q1: Mar 2023), $8.31 B(Q2: Jun 2023), $9.50 B(Q3: Sep 2023), $9.35 B(Q4: Dec 2023) in fiscal year 2023.

2022

Eli Lilly and Company's annual revenue was $28.54 B in fiscal year 2022.

Eli Lilly and Company's quarterly revenue was $7.81 B(Q1: Mar 2022), $6.49 B(Q2: Jun 2022), $6.94 B(Q3: Sep 2022), $7.30 B(Q4: Dec 2022) in fiscal year 2022.

2021

Eli Lilly and Company's annual revenue was $28.32 B in fiscal year 2021.

Eli Lilly and Company's quarterly revenue was $6.81 B(Q1: Mar 2021), $6.74 B(Q2: Jun 2021), $6.77 B(Q3: Sep 2021), $8.00 B(Q4: Dec 2021) in fiscal year 2021.

2020

Eli Lilly and Company's annual revenue was $24.54 B in fiscal year 2020.

Eli Lilly and Company's quarterly revenue was $5.86 B(Q1: Mar 2020), $5.50 B(Q2: Jun 2020), $5.74 B(Q3: Sep 2020), $7.44 B(Q4: Dec 2020) in fiscal year 2020.

2019

Eli Lilly and Company's annual revenue was $22.32 B in fiscal year 2019.

Eli Lilly and Company's quarterly revenue was $5.09 B(Q1: Mar 2019), $5.64 B(Q2: Jun 2019), $5.48 B(Q3: Sep 2019), $6.11 B(Q4: Dec 2019) in fiscal year 2019.

2018

Eli Lilly and Company's annual revenue was $21.49 B in fiscal year 2018.

Eli Lilly and Company's quarterly revenue was $4.96 B(Q1: Mar 2018), $5.59 B(Q2: Jun 2018), $5.31 B(Q3: Sep 2018), $6.44 B(Q4: Dec 2018) in fiscal year 2018.

2017

Eli Lilly and Company's annual revenue was $19.97 B in fiscal year 2017.

Eli Lilly and Company's quarterly revenue was $5.23 B(Q1: Mar 2017), $5.82 B(Q2: Jun 2017), $5.66 B(Q3: Sep 2017), $6.16 B(Q4: Dec 2017) in fiscal year 2017.

2016

Eli Lilly and Company's annual revenue was $21.22 B in fiscal year 2016.

Eli Lilly and Company's quarterly revenue was $4.87 B(Q1: Mar 2016), $5.40 B(Q2: Jun 2016), $5.19 B(Q3: Sep 2016), $5.76 B(Q4: Dec 2016) in fiscal year 2016.

... See more ... See more

Eli Lilly and Company's Revenue (Year-over-Year Change)

2015 0
2016 +6.33
2017 -5.88
2018 +7.61
2019 +3.84
2020 +9.95
2021 +15.40
2022 +0.79
2023 +19.56
2024 +32.00
2025 +44.70
Last Updated: Jun 30, 2026 |

2025

Eli Lilly and Company’s annual revenue increased +44.70% during fiscal year 2025 compared to 2024. It represents a growth of $20.14 B from $45.04 B (in 2024) to $65.18 B (in 2025). ... See more

2024

Eli Lilly and Company’s annual revenue increased +32.00% during fiscal year 2024 compared to 2023. It represents a growth of $10.92 B from $34.12 B (in 2023) to $45.04 B (in 2024).

2023

Eli Lilly and Company’s annual revenue increased +19.56% during fiscal year 2023 compared to 2022. It represents a growth of $5.58 B from $28.54 B (in 2022) to $34.12 B (in 2023).

2022

Eli Lilly and Company’s annual revenue increased +0.79% during fiscal year 2022 compared to 2021. It represents a growth of $223.00 M from $28.32 B (in 2021) to $28.54 B (in 2022).

2021

Eli Lilly and Company’s annual revenue increased +15.40% during fiscal year 2021 compared to 2020. It represents a growth of $3.78 B from $24.54 B (in 2020) to $28.32 B (in 2021).

2020

Eli Lilly and Company’s annual revenue increased +9.95% during fiscal year 2020 compared to 2019. It represents a growth of $2.22 B from $22.32 B (in 2019) to $24.54 B (in 2020).

2019

Eli Lilly and Company’s annual revenue increased +3.84% during fiscal year 2019 compared to 2018. It represents a growth of $826.20 M from $21.49 B (in 2018) to $22.32 B (in 2019).

2018

Eli Lilly and Company’s annual revenue increased +7.61% during fiscal year 2018 compared to 2017. It represents a growth of $1.52 B from $19.97 B (in 2017) to $21.49 B (in 2018).

2017

Eli Lilly and Company’s annual revenue decreased -5.88% during fiscal year 2017 compared to 2016. It represents a decline of $1.25 B from $21.22 B (in 2016) to $19.97 B (in 2017).

2016

Eli Lilly and Company’s annual revenue increased +6.33% during fiscal year 2016 compared to 2015. It represents a growth of $1.26 B from $19.96 B (in 2015) to $21.22 B (in 2016).

... See more ... See more

Eli Lilly and Company Revenue History

Sign in to download table

Period Revenue Year-over-Year Change
FY 2025
$65.18 B $20.14 B 44.7%
Q4: Dec 25 $19.29 B $5.76 B 42.56%
Q3: Sep 25 $17.60 B $6.16 B 53.87%
Q2: Jun 25 $15.56 B $4.25 B 37.64%
Q1: Mar 25 $12.73 B $3.96 B 45.17%
FY 2024
$45.04 B $10.92 B 32%
Q4: Dec 24 $13.53 B $4.18 B 44.68%
Q3: Sep 24 $11.44 B $1.94 B 20.43%
Q2: Jun 24 $11.30 B $2.99 B 35.98%
Q1: Mar 24 $8.77 B $1.81 B 25.98%
FY 2023
$34.12 B $5.58 B 19.56%
Q4: Dec 23 $9.35 B $2.05 B 28.1%
Q3: Sep 23 $9.50 B $2.56 B 36.84%
Q2: Jun 23 $8.31 B $1.82 B 28.11%
Q1: Mar 23 $6.96 B -$850.00 M 10.88%
FY 2022
$28.54 B $223.00 M 0.79%
Q4: Dec 22 $7.30 B -$698.10 M 8.73%
Q3: Sep 22 $6.94 B $168.80 M 2.49%
Q2: Jun 22 $6.49 B -$252.10 M 3.74%
Q1: Mar 22 $7.81 B $1.00 B 14.76%
FY 2021
$28.32 B $3.78 B 15.4%
Q4: Dec 21 $8.00 B $559.90 M 7.53%
Q3: Sep 21 $6.77 B $1.03 B 17.98%
Q2: Jun 21 $6.74 B $1.24 B 22.56%
Q1: Mar 21 $6.81 B $945.80 M 16.14%
FY 2020
$24.54 B $2.22 B 9.95%
Q4: Dec 20 $7.44 B $1.33 B 21.69%
Q3: Sep 20 $5.74 B $264.00 M 4.82%
Q2: Jun 20 $5.50 B -$137.30 M 2.44%
Q1: Mar 20 $5.86 B $767.60 M 15.07%
FY 2019
$22.32 B $826.20 M 3.84%
Q4: Dec 19 $6.11 B -$324.60 M 5.04%
Q3: Sep 19 $5.48 B $169.70 M 3.2%
Q2: Jun 19 $5.64 B $51.70 M 0.93%
Q1: Mar 19 $5.09 B $128.40 M 2.59%
FY 2018
$21.49 B $1.52 B 7.61%
Q4: Dec 18 $6.44 B $277.90 M 4.51%
Q3: Sep 18 $5.31 B -$351.10 M 6.21%
Q2: Jun 18 $5.59 B -$239.30 M 4.11%
Q1: Mar 18 $4.96 B -$264.50 M 5.06%
FY 2017
$19.97 B -$1.25 B 5.88%
Q4: Dec 17 $6.16 B $400.20 M 6.95%
Q3: Sep 17 $5.66 B $466.30 M 8.98%
Q2: Jun 17 $5.82 B $419.50 M 7.76%
Q1: Mar 17 $5.23 B $363.20 M 7.47%
FY 2016
$21.22 B $1.26 B 6.33%
Q4: Dec 16 $5.76 B $384.90 M 7.16%
Q3: Sep 16 $5.19 B $232.00 M 4.68%
Q2: Jun 16 $5.40 B $426.10 M 8.56%
Q1: Mar 16 $4.87 B $220.40 M 4.75%
Last Updated: Jun 30, 2026 |
Last updated Jun 30, 2026
Latest quarterly period ended Q2 FY2026 (June 30, 2026)
Latest annual period ended FY 2025 (December 31, 2025)
Data provided by Financial Modeling Prep
Original source Company Forms 10-Q and 10-K filed with the SEC
Methodology Company-reported financial data
Limitations Historical values may change because of company restatements or reclassifications
Links View source filings

Frequently Asked Questions

What is the annual revenue of Eli Lilly and Company?

In fiscal year 2025, Eli Lilly and Company's revenue was $65.18 Billion.

How much did Eli Lilly and Company's revenue change in the last year?

Eli Lilly and Company's revenue increased by +44.70% (+$20.14 Billion) in 2025 compared to 2024.

What is Eli Lilly and Company's most recent quarterly revenue?

In the second quarter (Q2) of 2026, Eli Lilly and Company reported a revenue of $22.97 Billion.

What is Eli Lilly and Company's revenue per share (TTM)?

Eli Lilly and Company's revenue per share over the trailing twelve months is $89.27.

What is Eli Lilly and Company's revenue per employee?

In the fiscal year 2025, Eli Lilly and Company's revenue per employee was $1.30 Million.

What is the annual net income of Eli Lilly and Company?

In fiscal year 2025, Eli Lilly and Company's net income was $20.64 Billion.

What is Eli Lilly and Company's biggest product segment, and what is its revenue?

Product is Eli Lilly and Company's biggest product segment, generating $60.96 Billion in revenue for fiscal year 2025.

What is Eli Lilly and Company's net income per employee?

In the fiscal year 2025, Eli Lilly and Company's net income per employee was $412.77 K.

Related

People Also Search For

Submit feedback to Bullfincher